Chemotherapy News and Research

Latest Chemotherapy News and Research

Researchers harness Zika virus vaccine under development to target glioblastoma

Researchers at The University of Texas Medical Branch at Galveston have successfully harnessed a Zika virus vaccine under development to target and kill the brain cancer known as glioblastoma.

19 Sep 2018

Tweaking nuclear pores could provide new avenue to battle against cancer

If the cell nucleus is like a bank for DNA, nuclear pores are the security doors around its perimeter. Yet more security doors aren't necessarily better: some cancer cells contain a dramatic excess of nuclear pores.

19 Sep 2018

Aluminum inclusions help enhance adsorption of chemo drugs onto active carbon delivery capsule

The efficacy of chemotherapy treatment depends on how effectively it reaches cancerous cells. Increasing targeted delivery could mean decreasing side effects.

18 Sep 2018

Zika virus vaccine shows promise for treatment of fatal glioblastoma

An international team of researchers has successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells, which had been transplanted into mice.

18 Sep 2018

Scientists explore whether seafood could be the source of next anti-cancer drug

Biomedical scientists at the University of Salford found that sugars from the common cockle were approximately as effective as some standard chemotherapy drugs at relative lower dosage.

17 Sep 2018

Adding PET scans to CT imaging can change treatment for women with cervical cancer

An Ontario clinical study that shows adding PET imaging to conventional CT imaging to stage locally advanced cervix cancer can change treatment means newly diagnosed women in this province may also receive PET imaging.

17 Sep 2018

Case Western Reserve professor wins $2 million grant to study colorectal cancer

Lan Zhou, MD, PhD, associate professor of pathology at Case Western Reserve University School of Medicine, has received a five-year, $2 million grant from the National Cancer Institute of the National Institutes of Health to study human colorectal cancer.

14 Sep 2018

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma -- an aggressive form of brain cancer with veryhttps://www.rush.edu/news/press-releases/rush-testing-new-brain-cancer-vaccine few current treatment options.

14 Sep 2018

Drug combination targets pre-leukemia stem cells

Your body's blood cells are manufactured by hematopoietic stem cells in bone marrow. But just as regular, mature cells can become cancerous, so too can stem cells.

12 Sep 2018

Screening does not reduce breast cancer mortality

Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the age groups that are not screened. The decline is therefore due to better treatment and not screening for breast cancer.

12 Sep 2018

Trying to protect seniors, the most vulnerable, from formidable foe Florence

Perhaps no other population is as vulnerable during a hurricane as frail, older adults, especially those who are homebound or living in nursing homes. With Hurricane Florence predicted to slam the North Carolina coast Friday, health officials are already scrambling to keep older residents safe.

12 Sep 2018

Researchers design new medicine to treat highly aggressive pancreatic cancer

A treatment for highly aggressive and commonly fatal pancreatic cancer is being developed, reports a University of Houston researcher who has designed a new medicine that can inhibit two of the major pathways of the deadly disease.

12 Sep 2018

Researchers untangle mysteries of 'evil' protein in ER-positive breast cancer

Breast cancer is one of the most common cancers in the United States, striking 1 out of 8 women. About 80 percent of all breast cancers are estrogen receptor-positive, in which cancer growth is fueled by estrogen.

12 Sep 2018

Scientists develop first DNA-based test for predicting risk of leukemia relapse

A group of Canadian and Korean scientists and physicians have developed the first DNA-based test that allows them to tell which patients will relapse after receiving chemotherapy and a bone marrow transplant, for their acute myeloid leukemia, or AML.

11 Sep 2018

Gene involved in circadian rhythms can be potential target for glioblastoma treatment

Scientists with the Virginia Tech Carilion Research Institute say a gene involved in the body's circadian rhythms is a potential target for therapies to help patients with a deadly form of brain cancer known as glioblastoma.

11 Sep 2018

Researchers identify new cancerous cells responsible for acute myeloid leukemia relapse

McMaster University researchers have provided evidence of new cancerous cells they have termed cancer regenerating cells, which are responsible for the return of acute myeloid leukemia after remission.

10 Sep 2018

Immune checkpoint inhibition may be effective in treating HIV-associated Kaposi's sarcoma

Among a small cohort of patients with HIV-associated Kaposi's sarcoma treated with immune checkpoint inhibitors, more than 65 percent had partial or complete remission.

7 Sep 2018

Study reinvestigates benefit of biomarker tests in certain breast cancer patients

The German Institute for Quality and Efficiency in Health Care reinvestigated the benefit of biomarker tests to support the decision for or against adjuvant systemic chemotherapy in certain breast cancer patients, that is, women with primary hormone receptor-positive, HER2/neu-negative breast cancer and 0 to 3 affected lymph nodes.

7 Sep 2018

Imaging with CMR can improve detection of cardiac injury in lupus patients

The number of diagnoses of systemic lupus erythematodes has tripled over the past 45 years - due in part to improved diagnostic methods.

7 Sep 2018

Research team identifies new therapeutic target for castration-resistant prostate cancer

A collaborative research team has linked the development of castration-resistant prostate cancer and resistance to treatment to a lack of androgen receptor expression in prostate cancer cells, identifying a new therapeutic target for one of the deadliest forms of cancer among men.

7 Sep 2018

Chemotherapy News and Research

Latest Chemotherapy News and Research

Researchers harness Zika virus vaccine under development to target glioblastoma

Tweaking nuclear pores could provide new avenue to battle against cancer

Aluminum inclusions help enhance adsorption of chemo drugs onto active carbon delivery capsule

Zika virus vaccine shows promise for treatment of fatal glioblastoma

Scientists explore whether seafood could be the source of next anti-cancer drug

Adding PET scans to CT imaging can change treatment for women with cervical cancer

Case Western Reserve professor wins $2 million grant to study colorectal cancer

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Drug combination targets pre-leukemia stem cells

Screening does not reduce breast cancer mortality

Trying to protect seniors, the most vulnerable, from formidable foe Florence

Researchers design new medicine to treat highly aggressive pancreatic cancer

Researchers untangle mysteries of 'evil' protein in ER-positive breast cancer

Scientists develop first DNA-based test for predicting risk of leukemia relapse

Gene involved in circadian rhythms can be potential target for glioblastoma treatment

Researchers identify new cancerous cells responsible for acute myeloid leukemia relapse

Immune checkpoint inhibition may be effective in treating HIV-associated Kaposi's sarcoma

Study reinvestigates benefit of biomarker tests in certain breast cancer patients

Imaging with CMR can improve detection of cardiac injury in lupus patients

Research team identifies new therapeutic target for castration-resistant prostate cancer

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in